Join
Live feed
·
INSIDERFilingvia Quantisnow
ReShape Lifesciences Inc. logo

Chief Financial Officer Stankovich Thomas sold $39 worth of shares (172 units at $0.23), decreasing direct ownership by 0.75% to 22,777 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RSLS· ReShape Lifesciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RSLS (ReShape Lifesciences Inc.) and more on Quantisnow.